Titlebook: Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models; J. Miguel Oliveira,Rui L. Reis Book 2020 Springer Nature Switzerland AG

Espionage

書目名稱Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models影響因子(影響力)




書目名稱Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models影響因子(影響力)學(xué)科排名




書目名稱Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models網(wǎng)絡(luò)公開度




書目名稱Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models被引頻次




書目名稱Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models被引頻次學(xué)科排名




書目名稱Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models年度引用




書目名稱Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models年度引用學(xué)科排名




書目名稱Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models讀者反饋




書目名稱Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models讀者反饋學(xué)科排名

鄙視

Microfluidics for Processing of Biomaterials,ic processing of biomaterials, mainly polymeric materials of natural origin, focusing on water-soluble polymers that form non-flowing phases after crosslinking. Some polysaccharides and proteins, including agarose, alginate, chitosan, gellan gum, hyaluronic acid, collagen, gelatin, and silk fibroin

GRILL

paragon

cathartic

Biomaterials and Microfluidics for Liver Models, engineered tissue construct were centered on the concept of seeding cells onto biomaterial scaffold. By means of innovative manufacturing machineries, the conception of a preformed scaffold became possible. Nowadays, several tissue engineering challenges are associated with applying this scaffold t

Merited

PACK

malign

Biomaterials and Microfluidics for Drug Discovery and Development,or pathogenesis. Together with the potential of biomaterials, its combination with microfluidics represents the ability to more closely mimic cells’ natural microenvironment concerning its three-dimensional (3D) nature and continuous perfusion with nutrients and cells’ crosstalk. Due to miniaturizat

Modify

Dynamic Culture Systems and 3D Interfaces Models for Cancer Drugs Testing,oduction of antibiotics. The use of dynamic systems, such as bioreactors, had been already applied in the food industry in fermentation processes and started being used for the development of pharmaceutical agents from this point on. In the last decades, the use of bioreactors and microfluidic syste

擴(kuò)張

Nanoparticles and Microfluidic Devices in Cancer Research,anotechnology has been presenting promising theranostic approaches to tackle cancer, as the development of nanoparticle-based therapies. But, regardless of the promising outcomes within . settings, its translation into the clinics has been delayed. One of the main reasons is the lack of an appropria